Screener
Beta Bionics BBNX Non Us — Total Assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Operating lease right-of-use asset | 5,816 | 6,627 |
| Long-term investments | 44,648 | 45,431 |
| Other long-term assets | 141 | 180 |
| Total assets | $292,387 | $328,743 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $5,351 | $4,998 |
| Accrued expenses and other current liabilities | 17,194 | 22,431 |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's non us — total assets?
- Beta Bionics (BBNX) reported non us — total assets of $0 in Q2 2026.
- What does non us — total assets mean?
- This metric measures the total value of tangible and intangible assets specifically allocated to or utilized by the company's operations in international markets. It reflects the capital investment required to support global distribution, local regulatory compliance, and international supply chain infrastructure. Monitoring this asset base provides insight into the company's commitment to global market penetration and the efficiency of capital deployment outside its home territory.
Ask your AI about Beta Bionics's non us — total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude